1. Home
  2. SCVL vs ESPR Comparison

SCVL vs ESPR Comparison

Compare SCVL & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCVL
  • ESPR
  • Stock Information
  • Founded
  • SCVL 1978
  • ESPR 2008
  • Country
  • SCVL United States
  • ESPR United States
  • Employees
  • SCVL N/A
  • ESPR N/A
  • Industry
  • SCVL Clothing/Shoe/Accessory Stores
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCVL Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • SCVL Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • SCVL 547.9M
  • ESPR 445.6M
  • IPO Year
  • SCVL 1993
  • ESPR 2013
  • Fundamental
  • Price
  • SCVL $24.61
  • ESPR $2.68
  • Analyst Decision
  • SCVL Hold
  • ESPR Buy
  • Analyst Count
  • SCVL 1
  • ESPR 6
  • Target Price
  • SCVL N/A
  • ESPR $6.50
  • AVG Volume (30 Days)
  • SCVL 487.6K
  • ESPR 5.8M
  • Earning Date
  • SCVL 09-04-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • SCVL 2.44%
  • ESPR N/A
  • EPS Growth
  • SCVL N/A
  • ESPR N/A
  • EPS
  • SCVL 2.27
  • ESPR N/A
  • Revenue
  • SCVL $1,153,927,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • SCVL N/A
  • ESPR $10.59
  • Revenue Next Year
  • SCVL $3.11
  • ESPR N/A
  • P/E Ratio
  • SCVL $10.84
  • ESPR N/A
  • Revenue Growth
  • SCVL N/A
  • ESPR N/A
  • 52 Week Low
  • SCVL $16.14
  • ESPR $0.69
  • 52 Week High
  • SCVL $46.92
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • SCVL 63.63
  • ESPR 84.78
  • Support Level
  • SCVL $20.61
  • ESPR $2.09
  • Resistance Level
  • SCVL $22.31
  • ESPR $2.29
  • Average True Range (ATR)
  • SCVL 1.00
  • ESPR 0.13
  • MACD
  • SCVL 0.37
  • ESPR 0.03
  • Stochastic Oscillator
  • SCVL 69.75
  • ESPR 95.77

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: